Hmm, first quarter GDP revised up again to +1.0%, existing home sales up 2% and the Dow Jones Industrial Average plunges 358 points to a new 2008 low. The S&P 500 closed below 1300, heading for a retest of its March low at 1270. This just shows you what $140 oil and the realization that GM and Citigroup are not going to make it this time can do.
The market continues to do what it does best, frustrating bulls and bears alike until it shakes everyone out of their positions, and then can make a major move up or down with no one benefiting. As I’ll discuss at the end of this Radar Report, I still think that we are seeing a classic double bottom and the next move will be up, so my best advice is to remain fully invested. But if you are feeling toyed with by the day-to-day market volatility, you are not alone.
In times like these it can be helpful to step back a bit and look at the big picture. I’ve been asking myself: “Where will the really big money be made over the next 10 years?” We all know that in the near term, say the next three years, the big drivers of this technology wave are:
- Universal connectivity, allowing everyone in the world to connect to the information, people and even objects (through RFID) that they need in order to function in the 21st century
- Voice-video-data (VVD) convergence, delivering everything seamlessly to both fixed and mobile connections
- Digital consumers, with the impending February 17, 2009 shut-down of analog television marking the end of the fastest growth period in this area
- Medical and biotechnology, which can continue as a major driver for decades if someone can get control of the dysfunctional FDA (my suggestion: Have them certify for safe dosage only)
- New energy technologies to cope with permanently higher oil prices, another driver that will continue for decades
But as broadband connections and cell phones become a given, like electricity, and hot water , what will be the new high-growth drivers to keep technology as the most important investment sector in the world? In my Money Show presentations, including the upcoming event on August 7 to 10 at the San Francisco Marriott, I talk about five currently-small high growth areas with great promise:
- China, where today’s short-term problems will be forgotten in five years, and we will be reinvesting after the dust settles
- Security, where 9/11 will never be forgotten and companies like American Science & Engineering (ASEI) face ever-increasing demand
- The New World Economy built on universal connectivity and VVD convergence
- Robotics, where there are very few investment alternatives beyond iRobot (IRBT)
- Nanotechnology, which has the potential impact of computers and biotechnology added together
Nanotechnology is in such an early stage that it is hard to find anything to invest in. Most of the best companies are still private. In the past, I’ve recommended hardware and software tools companies like Veeco (VECO) and Accelrys (ACCL), and I keep looking at FEI (FEIC) as a possible recommendation. We are already in a molecular-level materials company, Integral Technologies (ITKG.OB), which hit my $4 target price once and will do so again. But we don’t have a direct investment in nanotech, and we need one.
Harris & Harris (TINY) is not a nanotech company. It is a closed-end venture capital fund that invests in nanotech companies, which are mostly private. During the mania for nanotech in 2002 to 2004, it frequently sold for three to six times its net asset value. I saw strong buy recommendations in early 2005 at a 150% premium to net asset value.
Now, I grew up on a farm and still currently live on a farm, but I did not just fall off the turnip truck. Closed-end mutual funds like TINY normally trade at a discount to net asset value. When I am interested in a closed-end fund like H&Q Life Science Investors (HQL), I love to see a 15% to 20% discount to net asset value before I buy it. (HQL is currently at a 13.5% discount and starting to look interesting.) There’s been a lot of academic work on why closed-end funds normally trade at a discount, with the most popular theory being the potential taxes on the unrealized gains in the portfolio.
There are some circumstances where a premium to net asset value is justified. The Korea Fund (KF) often traded at a premium during the many years the Korean market was effectively closed to outside investors. But there is no circumstance where a 500% premium to net asset value can be justified, unless the fund is carrying Manhattan real estate at cost from 1908.
When I looked at TINY a couple of years ago, the premium to net asset value had fallen to about 100%–the new investor got to pay double what the portfolio was valued at. Gee, thanks. To be fair, venture capital companies usually carry an investment at cost until something happens. If the something is bad, they write the value down, reducing the net asset value of the fund. If it is good, like a new round of financing at a higher price, they write the value up but not all the way up–perhaps to 75% or 85% of the new valuation. Between financing events, even though the portfolio companies are presumably making progress, the fund normally does not increase the value of their shares. So while a small premium to net asset value might be justified to reflect the real current value of a portfolio of attractive private investments, 100% is better than 500% but still ridiculous.
Fast forward to today. TINY has a net asset value of $5.77, just 18 cents off their all-time high. The company just did a 2.5 million share, privately-placed equity financing at $6.15, a discount to their market price but a premium to their net asset value, so there was no dilution. But the stock promptly fell to $6.15, and the premium to net asset value fell to 6.6%. Now you’re talking! I can’t guarantee you that TINY won’t go to a discount to net asset value in the future (for the first time in its history), but I have followed their portfolio for several years and I like what I see. They own a $5.37 million position in Nanosys that accounts for 6.5% of their portfolio. Nanosys produces the building blocks of nanotechnology: nanowires, nanotubes and nanodots, and has long been my candidate for the Intel of nanotech. It could come public this year. Solazyme, which produces renewable diesel fuel from algae, is a $3.5 million position (4.2% of the portfolio) and another potential IPO this year, as is Molecular Imprints ($4.5 million; 5.4% of the portfolio). The entire TINY portfolio was shown in the March quarter shareholders’ letter:

The company reinvests its capital gains rather than paying them out, so compound interest can kick in with a vengeance once the IPO markets open up. I think that will happen sometime between October and next April, and two or three companies will go public. TINY will be able to sell some stock and add the proceeds to their current $53.6 million in cash. Even if the equity markets then shut down for a couple of years, TINY will be able to make more investments on very attractive terms to get ready for the next up cycle. If I’m wrong about a stock market downturn starting next April and it just keeps climbing, many more of their portfolio companies will become public, driving up the net asset value. Since their founding, nine of their portfolio companies have made it public, and four more were acquired. That’s an excellent record.
Their net asset value compounded at a 20.1% annual rate for the last five years, and I think they can keep that up for the next 10 to 20 years. Even if the premium to net asset value never expands again, that would be an excellent investment return. But, of course, the premium will expand in a better market for either IPOs or nanotechnology, or both, and give us an even better return on the stock.
One of the drains on the return TINY can provide is the increasing cost of bureaucracy on a small company. This is something to think about as we approach the Presidential election, because if the U.S. is ever going to get out of its current mire, most of the heavy lifting will be done by small and medium-size companies, and many of those will be producers or innovative users of technology. Additionally, I believe General Motors will file for bankruptcy before the end of 2009, possibly very early next year after management collects their bonuses, which will be a watershed event in passing the mass production baton from the U.S. to Asia. Taxing or over-regulating small business and entrepreneurs will simply impoverish the country as we muddle towards a new role on the world stage that can maintain our standard of living.
In 2002, TINY employed one internal accountant, one outside accounting firm, no corporate compliance consultants and no internal lawyers. Their annual audit cost $55,000. Five years later, thanks to the misbegotten Sarbanes-Oxley Act and, additional investment company reporting requirements, as well as Financial Accounting Standards Board proclamations on valuing assets, the company has two internal accountants, three accounting firms, three law firms, a compensation consulting firm, a compliance consultant, an asset-valuation consulting firm and two internal lawyers. Their 2007 audit cost $290,000, and their 2008 audit will be about $340,000. This is all for a company with 13 employees, including the lawyers.
Even under a Democratic administration, I don’t think the regulatory burdens will increase anywhere near as rapidly as they did in the last five years, so if TINY can grow its assets dramatically through some IPOs or acquisitions, the burden as a percentage of assets should fall and leave more income for us. But this is an area I will watch closely, as I don’t trust either Presidential candidate to do the right thing.
By investing in Harris & Harris, we get immediate exposure to 31 leading nanotech companies, each working on dramatic new products that will eventually revolutionize our lives. They won’t all work out, of course, but TINY management has a good record of picking winners, and they diversify enough so that even a complete failure won’t hurt the net asset value all that much. As the companies come public or get acquired, we’ll get a jump in the stock to reflect the higher net asset value, and then a further jump as the premium to net asset value expands because investors will get more bullish on nanotech after seeing some successful IPOs and big-ticket buyouts. I want you to take advantage of the weakness caused by this private placement and buy TINY up to $6.50 for a $10 target in 2009 and much higher levels in subsequent years.
The Harris & Harris Portfolio
- Adesto Technologies –Developing semiconductor-related products enabled at the nanoscale
- Ancora Pharmaceuticals – Developing synthetic carbohydrates for pharmaceutical applications
- BioVex –Developing novel biologics for treatment of cancer and infectious disease
- BridgeLux –Manufacturing high-power light emitting diodes
- Cambrios Technologies – Developingnanowire-enabled electronic materials for the display industry
- CFX Battery – Developing batteries using nanostructured materials
- Crystal IS –Developing single-crystal aluminum nitride substrates for optoelectronic devices
- CSwitch –Developing next-generation, system-on-a-chip solutions for communications-based platforms
- D-Wave Systems –Developing high-performance quantum computing systems
- Ensemble Discovery – Developing DNA Programmed Chemistry for the discovery of new classes of therapeutics and bioassays
- Evolved Nanomaterial Sciences – Developed nanoscale-enhanced approaches for the resolution of chiral molecules
- Exponential Business Development Company –Venture capital partnership focused on early stage companies
- Innovalight – Developing solar power products enabled by silicon-based nanomaterials
- Kereos –Developing emulsion-based imaging agents and targeted therapeutics to image and treat cancer and cardiovascular disease
- Kovio –Developing semiconductor products using printed electronics and thin-film technologies
- Mersana Therapeutics –Developing advanced polymers for drug delivery
- Metabolon – Discovering biomarkers through the use of metabolomics
- Molecular Imprints – Manufacturing nanoimprint lithography capital equipment
- NanoGram –Developing a broad suite of intellectual property utilizing nanoscale materials
- Nanomix –Producing nanoelectronic sensors that integrate carbon nanotube electronics with silicon microstructures
- Nanosys – Developing zero and one-dimensional inorganic nanometer-scale materials and devices
- Nantero – Developing a high-density, nonvolatile, random access memory chip, enabled by carbon nanotubes
- NeoPhotonics –Developing and manufacturing optical devices and components
- Nextreme Thermal Solutions – Developing thin-film thermoelectric devices for cooling and energy conversion
- Phoenix Molecular –Developing technology to enable the separation of difficult-to-separate materials
- Polatis –Developing MEMS-based optical networking components
- PolyRemedy –Developing a robotic manufacturing platform for wound treatment patches
- Questech – Manufacturing and marketing proprietary metal and stone decorative tiles
- Siluria Technologies –Developing next-generation nanomaterials
- SiOnyx – Developing silicon-based optoelectronic products enabled by its proprietary “Black Silicon”
- Solazyme – Developing algal biodiesel, industrial chemicals and special ingredients based on synthetic biology
- Starfire Systems –Producing ceramic-forming polymers
- Xradia –Designing, manufacturing and selling ultra-high resolution 3D x-ray microscopes and fluorescence imaging systems
- Zia Laser – Developed quantum dot semiconductor lasers
Content on Demand MegaShift
Infinera (INFN) drew an understandable question from Jeremy B.: “Can you please discuss your current opinion of Infinera? I’m worried that it may be time to sell this stock and would love to hear your feedback.”
I covered this in some detail in last week’s issue. They have one very large customer, Level 3, and some other 10%+ customers, so at this point they are vulnerable to any slowdown in spending from those four–and that is exactly what is happening this quarter. But they’ve just introduced their next-generation optical component, and it puts them at least three years ahead of the competition. We are at the inflection point where many more telecom companies have to start ordering, so the customer concentration issue will slowly fade away. Infinera uses a razor-and-blades business model, selling the boxes at little or no profit and then shipping add-on boards to scale up capacity at excellent profit margins. That’s why the Deutsche Telekom order will cost Infinera $4 million in losses over the next two quarters, even though it was a fantastic win with a Tier One customer, beating out all the other Tier One suppliers.
What will move the stock now is orders, orders, orders, and I think we’ll see several announcements before the end of the year and a virtual tsunami in 2009. So this is not the time to sell INFN, and if you don’t have a position, I would go ahead right now and buy INFN all the way up to $15 for a $30 target.
Michael H. asked: “Can you please comment on the risks of delisting for TKO and ZHNE? Now ZHNE has received a warning from NASDAQ. What are your thoughts about the near-term risks and long-term effects of such a possibility?”
The American Stock Exchange where Telkonet (TKO) is listed is much more tolerant of stocks trading for less than $1 a share, which is one reason companies move from NASDAQ to the AMEX. I think TKO’s results will have the stock well over $1 by the end of the year, so I’m not worried about them. TKO remains a buy up to $5 for my $15 target, a 2,700% return from current levels.
Zhone (ZHNE) is a different matter. Their choice is to figure out a way to get the stock up or leave the NASDAQ National Market for the OTC Bulletin Board where they will have lower liquidity. The quickest way to get the stock up in the short term is to do a reverse split, and even though the Zhone board is packed with financially sophisticated people, they often make this major mistake.
ZHNE has to trade above $1 for 10 business days in a row before December 8 to avoid delisting, and even if they can’t do that, they can appeal the decision. If we get the market rally I am expecting, they should be OK. If not, I will lobby the Board to not do a reverse split, but rather move to the Bulletin Board until they can get the stock price back up by posting good results instead of financial chicanery.
We don’t need to worry about this for a while, and I am keeping an eye on it. Meanwhile, ZHNE remains a buy up to $1.50 for my $4 target.
New Energy Technology MegaShift
Gasco Energy (GSX) is still under $4, and I find that amazing. Natural gas prices are up 80% over the last year, more than oil prices, and the futures market is saying they are not coming back down. The cold winter of 2007-2008 took gas inventories to very low levels, and the hot summer means electric utilities are burning lots of gas. That makes sense, because $12 gas equals about $75 oil, so there is no way a utility would choose to burn oil. If have a Gulf hurricane and natural gas spikes to $18 or $20, utilities will still burn it because oil would be at $170 to $200 a barrel.
The U.S. is not increasing liquid natural gas imports because we don’t have enough LNG terminals and because Europe and Japan are outbidding us for the stuff. So a company like Gasco is going to rake it in for the next many months, and GSX is a timely buy up to $4.50 for my $9 target by April 2009.
Subscriber MDC asked: “Can you explain why you think Holly Corp. (HOC) is going to rise? It seems to me the refinery business stinks right now.”
It sure does. That was the thesis when I recommended Holly Corp. (HOC). The stock was down because refinery margins had been squeezed as the price of oil rose faster than the price of refined products. I know it doesn’t feel that way when you are filling up the SUV, but it’s true. I thought the summer driving season would give the refiners their usual opportunity to widen the spread by keeping gas prices high. Although gas is high, oil keeps shooting up–including today’s record over $140–and investors sell off the refinery stocks.
As I’ve been saying, I think oil is at the high end of its trading range, barring the transient effects of a major hurricane. When the head of the Libyan oil company says oil is headed for $170, he is just “talking his book.” Maybe it will hit $170 on hurricane news, but oil has been in a parabolic increase for several months and the one thing we know about parabolic increases is that once they’ve gone vertical, they (a) can go higher, longer than the shorts would believe, and (2) they break viciously. So I think it is only a matter of time–a short time, at that–before you see HOC and the other refiners rally sharply. HOC remains a buy up to $48–a full $10 above the current price–for my $70 target.
U.S. Geothermal (HTM) held their first-ever financial conference call with about 30 participants after the close on Monday. I thought it went really well, but the stock sagged about 30 cents Tuesday and Wednesday, and then rocketed up 44 cents in today’s crummy market on the news that HTM will be added to the Russell 3000 index on June 27. It sagged for two days because they are having the normal start-up problems that need to be solved. I like this, both because management learns how to solve the problems as well as what to look out for, and also because it gives me insight into their honesty and openness. Lots of people can talk geothermal, but an experienced management team that has actually started up a few wells and a couple of power plants will make better acquisitions and run a tighter ship every time.
Currently, HTM is debating ways to increase the heat flow at Raft River, either by drilling a $1 million injection well or maybe a pair of wells for $5 million, one injection and one production. They’re also thinking about adding a small filtering plant to increase water quality. Another team is trying to reduce costs by convincing the regulators to let them monitor nearby wells for impact on a monthly or quarterly basis instead of weekly or even, in some cases, daily. These are all the things a company deals with once it goes from talking geothermal to producing geothermal, and they were not reasons to drop the stock. While I think the whole Russell index thing is silly and transient, I take some satisfaction in watching the stock move away from the sellers that knocked it down.
Not surprisingly, the company is seeing lots of deal flow, with other companies and entrepreneurs wanting to sell them geothermal properties, joint venture or sell a company. I predicted this in my original write-up, and all their current start-up issues just make them a more sophisticated buyer, able to ask tougher questions and do better due diligence before they pick their next deal.
The results of drilling tests at Neal Hot Springs should be out in 30 or 40 days, and that will drive the stock up next. There was some worry about Congress extending the renewable energy tax credits, and HTM management said a one-year extension is a lock, and the industry might be able to get a five-year extension if the Democrats win in November. HTM is a Top Buy up to $4 for my $6 first target, and I expect us to hold this stock for much higher prices over the next several years.
Robotics MegaShift
iRobot (IRBT) got a $3.3 million Department of Defense grant to develop a flexible robot that can move through spaces smaller than the robot’s overall dimensions. It would be used for search and rescue or urban reconnaissance. IRBT is just under my $15 buy limit, and I think the $30 target is still reasonable.
Market Outlook
The Fed spoke yesterday, the market liked it, and then the S&P 500 sailed over 1326…and couldn’t hold. That meant today would be bad, even before Goldman Sachs said to sell GM and short (!) Citigroup. But in the bigger scheme of things, we are only retesting the 1270 bottom in March (1255 in the overnight futures), and on the big monthly chart this is just a routine pullback. If you listen to CNBC, you will think it is the end of the modern financial era–that’s what you are supposed to think. As long as we bounce off 1270 (or 1255 at the worst), the set-up is still there for a slingshot move over 1326 to 1440. At that point we’ll learn if a move to new highs is still in the cards, or if the prospect of an Obama presidency is going to kneecap this market after Labor Day.

